Phase 1 Lung Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 years or older.
- People who have been diagnosed with locally advanced or metastatic solid tumour cancers (confirmed by laboratory testing of tissue or cell samples) that have a specific genetic change called a ROS1 fusion.
- People whose cancer can be measured using standard imaging guidelines (called RECIST version 1.1).
- People with a life expectancy of at least 3 months.
- Other criteria specified in the trial protocol may also apply (confirm with trial site).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are currently taking part in another clinical trial that involves a treatment or therapy.
- People who have a bowel or digestive condition (such as Crohn's disease, ulcerative colitis, or short gut syndrome) or any other condition that affects how the body absorbs medication.
- People who have a history of severe allergic reactions, or who have had a severe allergic or sensitivity reaction to any ingredient in the study drug.
- People who have a known active infection, whether bacterial or viral, including HIV.
- Other criteria specified in the trial protocol may also apply (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
The frequency and severity of adverse events of JYP0322
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.